Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!

Sanofi Appoints Bill Sibold to Replace David Meeker

  • Posted by Janet Tice
  • On April 6, 2017
Sanofi has announced the appointment of Bill Sibold as Executive Vice President Sanofi Genzyme, effective July 1, 2017.  In this role, Mr. Sibold will be a member of the Executive Committee. He succeeds David Meeker, M.D., who will leave the company at the end of June after a distinguished 23-year career with Genzyme and Sanofi. Mr. […]
Read More
 

Sanofi Genzyme and Regeneron Announce FDA Approval of First Targeted Biologic Therapy for Eczema

  • Posted by Janet Tice
  • On April 6, 2017
Sanofi and Regeneron Pharmaceuticals announced that the FDA has approved Dupixent, the first and only biologic medicine approved for the treatment of adults with moderate-to-severe atopic dermatitis (AD), a form of eczema, whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable. Dupixent is a human monoclonal antibody […]
Read More
 

Vertex Phase 3 Cystic Fibrosis Drug Trials Show Promising Results

  • Posted by Janet Tice
  • On April 6, 2017
Vertex Pharmaceuticals Incorporated has announced results from two Phase 3 studies of the tezacaftor/ivacaftor combination treatment that showed statistically significant improvements in lung function in people with cystic fibrosis (CF) ages 12 and older who have certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The 24-week EVOLVE study evaluated the combination treatment […]
Read More
 

Keys to Successful Interviews: Behavioral Questions Matter

  • Posted by rfeldt
  • On April 6, 2017
Asking “behavioral” questions during an interview can make you a better hiring manager. And if you’re on the receiving end, having good answers ready will help you ace the interview and land that coveted position. But what are behavioral questions, anyway? Screening candidates for soft skills is often the toughest part of an interviewing for […]
Read More
 

AiChE Boston Presents “Fundamentals of Bulk Solids Handling” on Saturday, April 29

  • Posted by ispeblog
  • On April 5, 2017
If you work with powders or other bulk solids and are interested in learning how to design bulk solid handling systems, this workshop is for you! Systems for handling powders and other bulk solids are often improperly designed, leading to: Erratic flow, no flow or limited throughputs Poor product quality and excessive downtime Customer complaints Safety issues including […]
Read More
 

Single Use Manufacturing & the Impact on Process, Facility Design & Procurement

  • Posted by jwillard
  • On April 3, 2017
Single use technology opens up a world of possibilities never considered before for biotech/pharma manufacturing but also brings with it a host of new challenges. As companies move from simple application of single use systems like bags (for buffer storage) to more complex single use systems and even entire single use facilities, the potential impact […]
Read More
 
 Featured Image

Making the Leap from Student to Industry Professional: Introducing the YPC…

  • Posted by Chris Ciampa
  • On March 31, 2017
The Young Professionals Committee (YPC) would like to introduce ourselves by showcasing each of the current committee members, telling you a little bit about ourselves and the paths our careers have taken.  To start, I have been the chair of the YPC for 2-3 years.  I work at Thermo Fisher Scientific, which is a supplier […]
Read More
 

Amgen in Thousand Oaks, CA to Lay Off, Relocate 500 Employees, Some to MA

  • Posted by jwillard
  • On March 30, 2017
The Pacific Coast Business Times is reporting that on March 22, Amgen notified nearly 500 employees at their Thousand Oaks facility that they will be re-assigned, relocated, or laid off over the next year and a half. The reassigned employees will be transferred to a new facility in Tampa Bay or to R&D in Cambridge, […]
Read More
 

Flexion Stock Soars on Report of Sanofi Takeover

  • Posted by Janet Tice
  • On March 30, 2017
As reported by Robert Weisman in The Boston Globe, following a report that Burlington-based Flexion Therapeutics is negotiating a sale to French drug giant Sanofi, Flexion shares rose more than 33 percent. Spokeswomen for Sanofi and Flexion — which has a promising knee pain drug up before US regulators — declined to comment. The purchase […]
Read More
 

EMD Serono Wins FDA Approval for Drug to Treat Skin Cancer

  • Posted by Janet Tice
  • On March 30, 2017
The FDA has granted accelerated approval to Bavencio (avelumab) for the treatment of metastatic Merkel cell carcinoma (MCC). This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer, and EMD Serono’s first cancer drug launch. The drug has been approved for adults and pediatric patients 12 years and older, […]
Read More